Cargando…
The use of protein phosphatase 2A activators in combination therapies for pancreas cancer
Autores principales: | Allen-Petersen, Brittany L., Sears, Rosalie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459339/ https://www.ncbi.nlm.nih.gov/pubmed/31007842 http://dx.doi.org/10.18632/oncotarget.26772 |
Ejemplares similares
-
Mission Possible: Advances in MYC Therapeutic Targeting in Cancer
por: Allen-Petersen, Brittany L., et al.
Publicado: (2019) -
Regulation and Function of Protein Kinases and Phosphatases
por: Cheng, Heung-Chin, et al.
Publicado: (2011) -
Targeting Protein-Tyrosine Phosphatases in Breast Cancer
por: Aceto, Nicola, et al.
Publicado: (2012) -
Microfluidics Formulated Liposomes of Hypoxia Activated Prodrug for Treatment of Pancreatic Cancer
por: Shah, Vidhi M., et al.
Publicado: (2022) -
Is Mitogen‐Activated Protein Kinase Phosphatase 5 a Solution to the Puzzle of the Mitogen‐Activated Protein Kinase Signal in Steatohepatitis?
por: Miura, Kouichi, et al.
Publicado: (2019)